Catalyst Wire Dossier Catalyst Wire Dossier

QBRELIS

LISINOPRIL · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QBRELIS, covering 2016-07-29 to 2017-07-28. Get the full timeline:

Most recent: FDA Approved: QBRELIS — Supplemental Application (Azurity Pharmaceuticals, Inc.)

See pricing